SWX:UBSN 24 November 2025

Swiss Stock Market Today, November 24, 2025: SMI Edges Higher as Tech Stocks Rally and UBS Legal Cases Weigh on Banks

The Swiss Market Index rose about 0.4% to 0.5% to near 12,680 on Monday, buoyed by global rate-cut hopes despite legal headlines around UBS and weak macro data. Logitech led blue-chip gains, up 3.6%, while ABB and Richemont also advanced. Defensive stocks like Roche and Swiss Re lagged. The SMI remains up roughly 8–9% for the year.

24 November 2025

Stock Market·SWX:ABBN·SWX:CFR·SWX:LOGN·SWX:UBSN

Organon (OGN) Shares Fall 58% in a Year: Is the Stock Undervalued?
March 14, 2026, 5:23 AM EDT. Organon's share price dropped 58.1% over the past year, closing at $6.35, raising concerns over its market valuation. Recent focus on Organon as a standalone women's health and biosimilars company highlights challenges post spin-off from its parent. A Discounted Cash Flow (DCF) analysis reveals an intrinsic value around $59.99, suggesting the stock is undervalued by approximately 89.4%. This reflects a large gap between market price and projected free cash flows, with 2023-2030 projections highlighting potential growth. Meanwhile, the Price-to-Earnings (P/E) metric indicates investor caution due to perceived risks and growth uncertainties. The mixed signals point to a market struggling to price Organon amid portfolio repositioning and capital allocation strategies.